FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:1138 April 13, 2000 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Lipscomb, G. H. PubMed Citation

To the Editor: Lipscomb et al. (Dec. 23 issue)¹ report on predictors of the success of methotrexate treatment in women with tubal ectopic pregnancies. In their study, ectopic pregnancy was diagnosed with the use of an algorithm incorporating measurements of serum chorionic gonadotropin and progesterone and the results of transvaginal ultrasonography. A single dose of methotrexate was offered to hemodynamically stable women who did not have free fluid outside the pelvic cavity, as determined by ultrasonography; who agreed to make weekly follow-up visits; who did not have renal, hepatic, or hematologic disease; and who did not desire surgical therapy. The . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Gamzu, R., Almog, B., Levin, Y., Pauzner, D., Lessing, J. B., Jaffa, A., Bar-Am, A. (2002). The ultrasonographic appearance of tubal pregnancy in patients treated with methotrexate. Hum Reprod 17: 2585-2587 [Abstract] [Full Text]